
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Polydeoxyribonucleotides
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases
Details : Polydeoxyribonucleotides is a Oligonucleotide drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Scleroderma, Localized.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Inapplicable
January 02, 2018
Lead Product(s) : Polydeoxyribonucleotides
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
